Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
5.11
+0.23 (4.71%)
Nov 6, 2025, 10:07 AM EST - Market open
Alvotech Employees
Alvotech had 1,012 employees as of December 31, 2024. The number of employees increased by 13 or 1.30% compared to the previous year.
Employees
1,012
Change (1Y)
13
Growth (1Y)
1.30%
Revenue / Employee
$555,808
Profits / Employee
$62,607
Market Cap
1.60B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,012 | 13 | 1.30% |
| Dec 31, 2023 | 999 | 82 | 8.94% |
| Dec 31, 2022 | 917 | 133 | 16.96% |
| Dec 31, 2021 | 784 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ALVO News
- 1 hour ago - Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA - GlobeNewsWire
- 1 hour ago - Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA - GlobeNewsWire
- 1 day ago - Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update - GlobeNewsWire
- 2 days ago - Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November - Benzinga
- 2 days ago - Alvotech Shares Plunge 33% After FDA Flags Issues - Benzinga
- 3 days ago - Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05 - GlobeNewsWire
- 15 days ago - Alvotech Announces Changes in Global Business Development and Commercial Operations Team - GlobeNewsWire
- 22 days ago - Alvotech: Promising Vertically Integrated Biosimilar Platform - Seeking Alpha